Document is current
Any future updates will be listed below
-
Authors
Neumann, Ulf https://orcid.org/0000-0001-6680-9177
Ufer, Mike
Jacobson, Laura H
Rouzade‐Dominguez, Marie‐Laure
Huledal, Gunilla
Kolly, Carine
Lüönd, Rainer M
Machauer, Rainer
Veenstra, Siem J
Hurth, Konstanze
Rueeger, Heinrich
Tintelnot‐Blomley, Marina
Staufenbiel, Matthias
Shimshek, Derya R
Perrot, Ludovic
Frieauff, Wilfried
Dubost, Valerie
Schiller, Hilmar
Vogg, Barbara
Beltz, Karen
Avrameas, Alexandre
Kretz, Sandrine
Pezous, Nicole
Rondeau, Jean‐Michel
Beckmann, Nicolau
Hartmann, Andreas
Vormfelde, Stefan
David, Olivier J
Galli, Bruno
Ramos, Rita
Graf, Ana
Lopez Lopez, Cristina https://orcid.org/0000-0003-4954-3754
-
Funding
Funding for this research was provided by:
Novartis Pharma AG, Basel, Switzerland
- License Information
-
More Information
Article History
Received: 9 May 2018
Revised: 23 August 2018
Accepted: 24 August 2018
First Online: 17 September 2018
Conflict of interest
: During the time this work was done, all authors have been employees and shareholders of Novartis Pharma AG, Basel, Switzerland. U. Neumann, Rainer M. Lueoend, Rainer Machauer, Siem J. Veenstra, Konstanze Hurth, Heinrich Rueeger, Marina Tintelnot‐Blomley, and Cristina Lopez Lopez are inventors in granted or pending patent applications.
